BioSpace News Archive

Business

Tom O’Lenic joins RedShiftBio as Chief Executive Officer

RedShift BioAnalytics, Inc. proudly announces the appointment of Tom O’Lenic as its new Chief Executive Officer (CEO).

March 7, 2024
·
3 min read
Genetown

Dianthus Therapeutics Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4) - March 07, 2024

Dianthus Therapeutics, Inc. announced that it granted an equity award on March 2, 2024, to a newly-hired, non-executive employee.

March 7, 2024
·
1 min read
Policy

Cyteir Announces Timeline for Voluntarily Delisting from Nasdaq - March 07, 2024

Cyteir Therapeutics, Inc. announced that it has formally notified The Nasdaq Stock Market of its intent to delist the Company’s common stock from the Nasdaq Global Select Market.

March 7, 2024
·
2 min read
Kimer Med, innovative New Zealand biotech start-up, signs contract with Battelle Memorial Institute to pioneer antiviral drug advances

Kimer Med, a New Zealand-based biotech start-up, announced it has signed a contract valued at up to USD$750,000 with Battelle, the world’s largest independent, nonprofit research and development organisation.

March 7, 2024
·
3 min read
Advancing Healthcare Access: Genesis MedTech Teams Up with Silk Road Medical to Serve Patients affected by Carotid Artery Disease in China

Silk Road Medical, a medical device company based in California USA and Genesis MedTech Group have signed an exclusive distribution agreement to introduce the TCAR® core products, ENROUTE® Transcarotid Neuroprotection System and ENROUTE® Transcarotid Stent System, in China.

March 7, 2024
·
5 min read
Business

Alkermes Announces Appointment of Nancy S. Lurker to Board of Directors

Alkermes plc (Nasdaq: ALKS) today announced the appointment of a new independent director, Nancy S. Lurker, to the company’s Board of Directors (the Board).

March 7, 2024
·
4 min read
Biotech Bay

CERo Therapeutics, Inc. Announces Publication of Preclinical Research Supporting the Use of Its Clinical Candidate CER-1236 to Treat AML Patients

CERo Therapeutics Holdings, Inc., today announced the publication in Clinical Cancer Research , a journal of the American Association for Cancer Research, a paper titled “ Therapeutic Targeting of TIM-4-L With Engineered T Cells for Acute Myeloid Leukemia.”

March 7, 2024
·
4 min read
Drug Development

Alphyn Announces Positive Results from Second Cohort of Phase 2a Clinical Trial in Atopic Dermatitis

Alphyn announced today that the second cohort of its Phase 2a trial evaluating zabalafin hydrogel (AB-101a) in patients with atopic dermatitis (AD) and infected AD skin met all endpoints for safety and efficacy.

March 7, 2024
·
5 min read
Business

Alimera Sciences Reports Fourth Quarter and Full Year 2023 Results

Alimera Sciences, Inc. today announced financial results for the fourth quarter and full year 2023.

March 7, 2024
·
16 min read
Clene to Present at the 36th Annual ROTH Conference

Clene Inc. today announced that it will participate in the 36th Annual ROTH Conference being held March 18-19, 2024.

March 7, 2024
·
1 min read